"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

A new study published in the Journal of Stroke and Cardiovascular Disease showed that continuous positive airway pressure ...

The first UK patients have been fitted with the Genio Nyxoah implant, a new treatment for sleep apnoea which stimulates the ...

The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the ...

A new study found that peer support improved CPAP adherence and patient satisfaction, which can improve sleep and overall health. Continuous positive airway pressure, or CPAP, therapy can improve ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...